Q32 Bio Inc.

8-K Entered a material agreement Jul 15, 2026 8-K Other events Jul 13, 2026 8-K Regulation FD disclosure; Other events Jul 13, 2026 8-K Shareholder vote results Jun 16, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events May 27, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Other events Apr 24, 2026 8-K Entered a material agreement Mar 27, 2026 10-K Fiscal year ended 2025-12-31 Mar 10, 2026 8-K Results of operations (earnings release) Mar 10, 2026 8-K Entered a material agreement; Other events Feb 17, 2026 8-K Director or officer change Dec 19, 2025 8-K Entered a material agreement; Terminated a material agreement; Completed an acquisition or disposition; Regulation FD disclosure; Other events Dec 1, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Other events Oct 21, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Director or officer change; Regulation FD disclosure Jun 25, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results Jun 17, 2025 8-K Delisting notice or listing-rule failure May 23, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Director or officer change Apr 25, 2025 10-K Fiscal year ended 2024-12-31 Mar 11, 2025 8-K Results of operations (earnings release) Mar 11, 2025 8-K Other events Mar 10, 2025 8-K Exit or disposal costs; Regulation FD disclosure Feb 10, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Regulation FD disclosure; Other events Dec 11, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Regulation FD disclosure; Other events Jul 9, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 10-K/A Fiscal year ended 2023-12-31 Apr 12, 2024 8-K Entered a material agreement; Completed an acquisition or disposition; Results of operations (earnings release); Took on a direct financial obligation; Unregistered sale of equity; Modified rights of security holders; Changed accountants; Change in control; Director or officer change; Amended charter or bylaws; Item 5.06; Regulation FD disclosure Mar 27, 2024